CORRECTION: MEI Pharma Q1 EPS $8.46 Beats $(2.12) Estimate, Sales $65.30M Up From $8.73M YoY
Portfolio Pulse from Benzinga Newsdesk
MEI Pharma reported Q1 earnings of $8.46 per share, beating the analyst consensus estimate of $(2.12) by 499.06 percent. This is a 425.38 percent increase over losses of $(2.60) per share from the same period last year. The company reported $65.30 million in sales this quarter, a 647.96 percent increase over sales of $8.73 million the same period last year.
November 09, 2023 | 10:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
MEI Pharma's Q1 earnings significantly beat estimates and sales increased substantially YoY.
MEI Pharma's Q1 earnings significantly exceeded analyst estimates, and the company reported a substantial increase in sales compared to the same period last year. This positive financial performance is likely to have a positive impact on the company's stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100